Gara Jalqabaatti › Kansaar Onnee Triple-Negative › Kansas
Qorannoo klinikaalii Kansaar Onnee Triple-Negative Kansas keessatti
Qorannoo 5 Kansaar Onnee Triple-Negative f Kansas keessatti hirmaatuu jiru.
Takkalaa qorannoo (Ingiliffa)
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- University of Kansas, Westwood
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07020117Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
- Cancer Center of Kansas, Wichita
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT05633654Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
- Hays Medical Center Dreiling-Schmidt Cancer Institute, Hays
- KCCC West, Kansas City
- KCCC Overland Park, Overland Park
- fi 3 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin hundi · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT02302742Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- University of Kansas Medical Center (KUMC), Westwood
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT05579366A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer
- The University of Kansas Hospital, Westwood
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ama-2026 · NCT06926920Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.